News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
777,484 Results
Type
Article (77360)
Company Profile (669)
Press Release (699455)
Section
Business (211450)
Career Advice (3359)
Deals (37692)
Drug Delivery (122)
Drug Development (86842)
Employer Resources (172)
FDA (17188)
Job Trends (16683)
News (364597)
Policy (35945)
Tag
Academia (2973)
Alliances (52822)
Alzheimer's disease (1417)
Approvals (17150)
Artificial intelligence (228)
Bankruptcy (350)
Best Places to Work (12600)
Biotechnology (458)
Breast cancer (240)
Cancer (1810)
Cardiovascular disease (140)
Career advice (2838)
CAR-T (138)
Cell therapy (393)
Clinical research (69344)
Collaboration (713)
Compensation (381)
COVID-19 (2801)
C-suite (175)
Data (1673)
Diabetes (220)
Diagnostics (6767)
Earnings (80821)
Employer resources (150)
Events (121877)
Executive appointments (602)
FDA (18137)
Funding (645)
Gene therapy (274)
GLP-1 (733)
Government (4925)
Healthcare (20752)
Infectious disease (2923)
Interviews (632)
IPO (17605)
Job creations (4596)
Job search strategy (2374)
Layoffs (514)
Legal (8508)
Lung cancer (267)
Manufacturing (262)
Medical device (14401)
Medtech (14406)
Mergers & acquisitions (20499)
Metabolic disorders (594)
Neuroscience (1861)
NextGen: Class of 2025 (7556)
Non-profit (5065)
Northern California (2145)
Obesity (324)
Opinion (259)
Patents (170)
People (63051)
Pharmaceutical (139)
Phase I (21471)
Phase II (30219)
Phase III (22682)
Pipeline (731)
Postmarket research (3228)
Preclinical (9657)
Radiopharmaceuticals (262)
Rare diseases (351)
Real estate (7046)
Regulatory (24385)
Research institute (2637)
Resumes & cover letters (518)
Southern California (1853)
Startups (3919)
United States (19717)
Vaccines (697)
Weight loss (237)
Date
Today (16)
Last 7 days (636)
Last 30 days (2756)
Last 365 days (36787)
2025 (4754)
2024 (37614)
2023 (42362)
2022 (53778)
2021 (58584)
2020 (57558)
2019 (51156)
2018 (38858)
2017 (35502)
2016 (35579)
2015 (41852)
2014 (35838)
2013 (33472)
2012 (33738)
2011 (33836)
2010 (33215)
Location
Africa (1100)
Arizona (214)
Asia (45640)
Australia (8219)
California (4990)
Canada (1743)
China (416)
Colorado (228)
Connecticut (255)
Europe (105884)
Florida (712)
Georgia (177)
Illinois (523)
Indiana (280)
Maryland (806)
Massachusetts (3898)
Michigan (220)
Minnesota (362)
New Jersey (1418)
New York (1416)
North Carolina (982)
Northern California (2145)
Ohio (186)
Pennsylvania (1134)
South America (1453)
Southern California (1853)
Texas (745)
Utah (152)
Washington State (514)
777,484 Results for "tisch ms research center of new york".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
First FDA-Approved Phase II Stem Cell Treatment Study Shows Significant Improvements in Progressive MS Patients
The Tisch MS Research Center of New York, the world’s largest MS research center, has announced publication of the results of its FDA-approved Phase II stem cell treatment study in a leading stem cell journal, Stem Cell Research & Therapy.
June 5, 2024
·
4 min read
Job Trends
5 Biopharma Companies Hiring in New York
Check out five New York companies hiring biopharma professionals like you, including 2025 Best Places to Work winners.
November 21, 2024
·
1 min read
·
Chantal Dresner
Pharm Country
Tisch Multiple Sclerosis Research Center of New York Study Featured in BioSpace
The Tisch Multiple Sclerosis Research Center of New York, the world’s largest independent research center focusing on MS, is proud to announce that its FDA-approved stem cell treatment study was featured in an article in BioSpace.
June 29, 2022
·
1 min read
Press Releases
Celerion Expands UK Phase 1 Clinical Research Operations With New Agreement to Relocate to Queen’s University Belfast’s iREACH Health – Clinical Research Innovation Center
February 19, 2025
·
2 min read
BioMidwest
Valent BioSciences Opens New State-of-the-Art Addition at Melnik and Shafer Biorational Research Center
Valent BioSciences celebrated the grand opening of the new Venburg Wing at the company’s Melnik and Shafer Biorational Research Center in Libertyville, Illinois, during a special ceremony.
May 29, 2024
·
3 min read
Business
Lynx.MD Partners with New York Gastroenterology Associates to Enhance Gastrointestinal Research Efforts
Committed to advancing gastrointestinal research, Lynx.MD, the industry-leading medical data intelligence platform tailored specifically for the gastroenterology market, announces its collaboration with New York Gastroenterology Associates.
May 15, 2024
·
3 min read
Pharm Country
Astrin Biosciences and Leading New York Cancer Center Announce New Cancer Research Collaboration
In a significant advancement for cancer research and treatment, Astrin Biosciences, a leader in AI-empowered 3D holographic technology for cancer cell detection, has announced a comprehensive research collaboration with Memorial Sloan Kettering Cancer Center.
January 24, 2024
·
1 min read
BioMidwest
Anteris Provides Data Update on First in Human Study of DurAVR™ THV Presented at New York Valves 2024
Anteris Technologies Ltd announced a summation of the Company’s presentation at the New York Valves annual Conference held at the Jacob K. Javits Convention Center in New York City.
June 11, 2024
·
4 min read
Pharm Country
Primary Progressive MS Is Confirmed To Be Distinct From Other MS Subtypes
The Tisch MS Research Center of New York, the world’s largest independent research center focused on multiple sclerosis, has published groundbreaking new research classifying primary progressive multiple sclerosis as pathophysiologically distinct from other forms of MS.
February 6, 2023
·
3 min read
Press Releases
Protagonist to Host Investor Event with KOL Insights on Polycythemia Vera (PV) and the Hepcidin Mimetic Rusfertide in New York on February 6, 2025
January 30, 2025
·
6 min read
1 of 77,749
Next
